Home › Calculator › IVA Dividend Calculator 2026
IVA Dividend DRIP Calculator 2026
41.84% YieldHealthcareInventiva S.A. · NASDAQ
Price: $4.78 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IVA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your IVA snowball 📈
$10,000 in IVA → $15.15M in 10 years · $515.74/month
About Inventiva S.A. (IVA) — Dividend Analysis 2026
Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets serious conditions such as non-alcoholic steatohepatitis (NASH), various forms of mucopolysaccharidoses (MPS), and other significant diseases. The company's most advanced experimental drug is Lanifibranor, which has successfully completed Phase IIb clinical trials for the treatment of NASH. Inventiva is also progressing with Odiparcil, an asset that has finished its Phase IIa clinical studies for addressing the MPS VI subtype disease. Beyond these lead candidates, Inventiva maintains a robust pipeline of earlier-stage research and development programs, notably in oncology and other therapeutic areas. The company has also established important strategic alliances, including a partnership with AbbVie focused on treatments for autoimmune diseases, and a collaboration with Boehringer Ingelheim International GmbH aimed at discovering novel therapies for idiopathic pulmonary fibrosis. Inventiva S.A. was established in 2011 and is headquartered in Daix, France.
Compare IVA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IVA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IVA position with:
🌍 IVA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IVA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 41.84% | 39.04% | $4,184 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 35.56% | 32.76% | $3,556 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 33.47% | 30.67% | $3,347 / yr |
| 🇬🇧 UK ISA | 0% | 41.84% | 39.04% | $4,184 / yr |
| 🇬🇧 UK Taxable | 8.75% | 38.18% | 35.38% | $3,818 / yr |
| 🇨🇦 TFSA | 0% | 41.84% | 39.04% | $4,184 / yr |
| 🇨🇦 CA Taxable | 25% | 31.38% | 28.58% | $3,138 / yr |
| 🇦🇺 Super (pension) | 15% | 35.56% | 32.76% | $3,556 / yr |
| 🇦🇺 AU Taxable | 30% | 29.29% | 26.49% | $2,929 / yr |
| 🇩🇪 DE Taxable | 26.375% | 30.80% | 28.00% | $3,080 / yr |
| 🇫🇷 FR Taxable | 30% | 29.29% | 26.49% | $2,929 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IVA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IVA Dividend Payment Schedule
IVA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 IVA vs Healthcare Benchmarks
How IVA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IVA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IVA Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where IVA earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IVA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Inventiva S.A. (IVA) is currently trading at $4.78, 70% below its 52-week high. The current dividend yield is 41.84% based on an annual payout of $2.00 per share.
IVA (Inventiva S.A.) — 41.84% Dividend Yield Analysis
Inventiva S.A. (IVA) is a healthcare stock currently trading at $4.78 with a dividend yield of 41.84%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (41.84%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.